Cargando…
Research Progress of N6-Methyladenosine in the Cardiovascular System
According to the World Health Organization cardiovascular disease risk charts, the mortality rate of cardiovascular diseases in people is still high. The medical expenses caused by cardiovascular diseases are increasing daily, and the medical burden is becoming heavier; as such, it is imperative to...
Autores principales: | Zheng, Nan, Su, Jia, Hu, Haochang, Wang, Jingqiao, Chen, Xiaomin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207004/ https://www.ncbi.nlm.nih.gov/pubmed/32350237 http://dx.doi.org/10.12659/MSM.921742 |
Ejemplares similares
-
Roles of N6‐Methyladenosine Demethylase FTO in Malignant Tumors Progression
por: Zheng, Qing-Kang, et al.
Publicado: (2021) -
Research advances of N6‐methyladenosine in diagnosis and therapy of pancreatic cancer
por: Chen, Sai, et al.
Publicado: (2022) -
The Role of N(6)-Methyladenosine Modification in Microvascular Dysfunction
por: Zhang, Ye-Ran, et al.
Publicado: (2022) -
N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
por: Liu, Chi, et al.
Publicado: (2022) -
The potential role of RNA N6-methyladenosine in Cancer progression
por: Wang, Tianyi, et al.
Publicado: (2020)